Ena Respiratory
Melbourne
About Ena Respiratory
Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines. Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterial dissemination to the lungs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $68.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: enarespiratory.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/ena-respiratory-44616 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.